Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Equillium Inc
(NQ:
EQ
)
1.390
-0.040 (-2.80%)
Streaming Delayed Price
Updated: 1:27 PM EDT, May 23, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Equillium Inc
< Previous
1
2
Next >
Equillium Buys Inflammatory Bowel Disease Player In All-Stock Deal
September 07, 2022
Via
Benzinga
Why CinCor Pharma Is Trading Higher By 63%, Here Are 79 Stocks Moving In Monday's Mid-Day Session
August 08, 2022
Gainers Bonso Electronics International Inc. (NASDAQ: BNSO) shares jumped 132% to $11.12 after jumping around 46% on Friday. The company recently said it expects unaudited comprehensive loss of $1.6...
Via
Benzinga
89 Biggest Movers From Friday
June 21, 2022
Gainers Revlon, Inc. (NYSE: REV) jumped 91.3% to close at $3.73 on Friday after the company filed for Chapter 11 bankruptcy.
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 15, 2022
Via
Benzinga
Approval Of Baricitinib For Patchy Baldness Validates Clinical Patch For This Small-Cap Stock
June 14, 2022
Via
Benzinga
Stocks That Hit 52-Week Lows On Friday
May 27, 2022
During Friday's session, 59 stocks hit new 52-week lows.
Via
Benzinga
Equillium's Itolizumab Shows Durable Clinical Response In GvHD Patients
March 23, 2022
Equillium Inc (NASDAQ: EQ) announced two oral presentations on itolizumab at the Annual Meeting of the European Society for Blood and Marrow Transplantation.
Via
Benzinga
Stocks That Hit 52-Week Lows On Thursday
March 17, 2022
Thursday saw 34 companies set new 52-week lows. Facts of Interest About Today's 52-Week Lows: SecureWorks (NASDAQ:SCWX) was the largest company by market cap to...
Via
Benzinga
Equillium Adds Three Drugs To Its Pipeline Via Bioniz Acquisition
February 16, 2022
Equillium Inc (NASDAQ: EQ), with only one asset in its pipeline, is expanding its drug development efforts via the acquisition of Bioniz Therapeutics. The deal,...
Via
Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
January 21, 2022
Gainers Mustang Bio (NASDAQ:MBIO) shares ...
Via
Benzinga
10 Biggest Price Target Changes For Wednesday
January 05, 2022
UBS cut the price target for Adobe Inc. (NASDAQ: ADBE) from $635 to $575. Adobe shares fell 2.3% to $541.06 in pre-market trading. SVB Leerink lowered the price target on...
Via
Benzinga
45 Biggest Movers From Yesterday
January 05, 2022
Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced...
Via
Benzinga
Equillium To Reassess Potential For Its Asthma Trials
January 04, 2022
Equillium Inc's (NASDAQ: EQ) Phase 1b EQUIP study of itolizumab in patients with uncontrolled asthma met its primary objective. The data demonstrated an on-target...
Via
Benzinga
Equillium Reveals Early Safety Data For Itolizumab In Lupus Patients
November 02, 2021
Equillium Inc (NASDAQ: EQ) announced interim data from the Type A portion of the Phase 1b EQUALISE study in systemic lupus erythematosus (SLE) patients. Data were...
Via
Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For September 15, 2021
September 15, 2021
Upgrades For Alcoa Corp (NYSE:
Via
Benzinga
Equillium's Itolizumab Reduces Urine Protein In Lupus Patients
August 12, 2021
Equillium Inc (NASDAQ: EQ) announced additional data from the Type A portion of the EQUALISE Phase 1b study of itolizumab in systemic lupus erythematosus (SLE) and...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's After-Market Session
August 11, 2021
Gainers Hims & Hers Health (NYSE:HIMS)...
Via
Benzinga
The Week Ahead In Biotech (Oct. 31-Nov. 6): Earnings Pick Up Pace, Eton Awaits Seizure Drug Approval, Kidney Conference, More IPOs In The Pipeline
October 31, 2021
Biotech stocks rose a third week running in the week ending Oct. 29 amid positive reaction to earnings. Big pharma earnings were mostly better than expected. Merck & Co, Inc...
Via
Benzinga
60 Biggest Movers From Yesterday
August 24, 2021
Gainers Trillium Therapeutics Inc. (NASDAQ: TRIL) shares jumped 188.8% to close at $17.59 on Monday after the company agreed to be acquired by Pfizer for $18.50 per share,...
Via
Benzinga
Equillium's Single Phase 3 Study In aGVHD To Support US Filing Of Itolizumab
July 13, 2021
Equillium Inc (NASDAQ: EQ) completed an End-of-Phase 1 meeting with the FDA, confirming to advance itolizumab into a single Phase 3 pivotal study in first-line...
Via
Benzinga
Exposures
Product Safety
12 Health Care Stocks Moving In Monday's After-Market Session
July 12, 2021
Gainers SCWorx (NASDAQ:WORX) shares rose...
Via
Benzinga
The Daily Biotech Pulse: Equillium Issues Positive Regulatory Update, Biogen In-Licenses Multiple Sclerosis Drug, Aridis Releases COVID-19 Antibody Cocktail Data
July 13, 2021
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 12) AbbVie Inc. (NYSE: ABBV)...
Via
Benzinga
Exposures
COVID-19
12 Health Care Stocks Moving In Friday's Intraday Session
June 11, 2021
Gainers Novan (NASDAQ:NOVN) stock rose 71.04% to $15.46 during Friday's regular session. As of 12:30 EST, Novan's stock is trading at a volume of 109.3 million,...
Via
Benzinga
64 Biggest Movers From Friday
June 14, 2021
Gainers Kanzhun Limited (NASDAQ: BZ) shares climbed 95.8% to close at $37.20 on Friday after the company priced its IPO at $19 per share. Novan, Inc. (NASDAQ: NOVN) shares gained...
Via
Benzinga
Topics
Initial Public Offering
Exposures
Securities Market
Equillium's Itolizumab Shows Rapid, Durable Responses In Graft-Versus-Host-Disease Patients
June 11, 2021
Equillium Inc (NASDAQ: EQ) has announced positive topline data from the Phase 1b EQUATE study evaluating itolizumab in first-line acute graft-versus-host-disease (...
Via
Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
June 09, 2021
Gainers Aethlon Medical (NASDAQ:AEMD) stock rose 248.41% to $7.7 during Wednesday's pre-market session. The market value of their outstanding shares is at $93.4...
Via
Benzinga
The Week Ahead In Biotech: Biogen, Alexion And Vertex FDA Decisions, Multiple Conference Presentations On The Deck
June 07, 2021
Biopharma stocks advanced in the truncated week ended June 4 amid the broader market strength. The American Society for Clinical Oncology meeting got underway during the week,...
Via
Benzinga
Exposures
Product Safety
46 Biggest Movers From Yesterday
April 21, 2021
Gainers Brooklyn ImmunoTherapeutics, Inc. (NYSE: BTX) shares jumped 27.3% to close at $9.79 on Tuesday after the company reported inducement grants. The company recently said it...
Via
Benzinga
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.